Current perspectives on the use of alternative species in human health and ecological hazard assessments

Environmental Health Perspectives

Volumn 121, Issue 9, 2013, Pages 1002-1010

  Perkins, Edward J ^a   Ankley, Gerald T ^b   Crofton, Kevin M ^b   Garcia Reyero, Natàlia ^c   LaLone, Carlie A ^b   Johnson, Mark S ^d   Tietge, Joseph E ^b   Villeneuve, Daniel L ^b  

^a US ARMY ENGINEER RESEARCH AND DEVELOPMENT CENTER   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c MISSISSIPPI STATE UNIVERSITY   (United States)

^d US Army Institute of Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1, 1 DICHLORO 2, 2 BIS (4 CHLOROPHENYL) ETHYLENE; 4, 4' ISOPROPYLIDENEDIPHENOL; ATRAZINE; ESTRADIOL; ETHINYLESTRADIOL; FADROZOLE; FENARIMOL; FIPRONIL; FLUSILAZOLE; FLUTAMIDE; KETOCONAZOLE; METHOXYCHLOR; METHYLTESTOSTERONE; PROCHLORAZ; PROMETON; PROPICONAZOLE; TRENBOLONE; UNCLASSIFIED DRUG; VINCLOZOLIN; VITELLOGENIN; SILANE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL TESTING ALTERNATIVE; DRUG EXPOSURE; ECOTOXICOLOGY; ENVIRONMENTAL EXPLOITATION; ENVIRONMENTAL HEALTH; HAZARD ASSESSMENT; HEALTH HAZARD; HIGH THROUGHPUT SCREENING; HUMAN; IN VITRO STUDY; METABOLISM; NONHUMAN; POLLUTION; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; REVIEW; RISK ASSESSMENT; ANIMAL; ANIMAL MODEL; CYPRINIFORMES; DOSE RESPONSE; PROCEDURES; SPECIES DIFFERENCE; STANDARDS; TOXICITY; TOXICITY TESTING; TRENDS; XENOPUS LAEVIS; ZEBRA FISH;

ANIMALIA; DANIO RERIO; MAMMALIA; PIMEPHALES PROMELAS; XENOPUS LAEVIS;

ANIMAL TESTING ALTERNATIVES; ANIMALS; CYPRINIDAE; DOSE-RESPONSE RELATIONSHIP, DRUG; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MODELS, ANIMAL; RISK ASSESSMENT; SILANES; SPECIES SPECIFICITY; TOXICITY TESTS; TRIAZOLES; XENOPUS LAEVIS; ZEBRAFISH;

EID: 84883283839     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1306638     Document Type: Review

References (108)

1. Adamska M, Degnan SM, Green KM, Adamski M, Craigie A, Larroux C, et al. 2007. Wnt and TGF-β expression in the sponge Amphimedon queenslandica and the origin of metazoan embryonic patterning. PLoS One e1031; doi:10.1371/journal.pone.0001031.
2. Ali S, Mil HGJV, Richardson MK. 2011. Large-scale assessment of the zebrafish embryo as a possible predictive model in toxicity testing. PLoS One 6:e21076; doi:10.1371/journal.pone.0021076.
3. Ankley GT, Bencic DC, Breen MS, Collette TW, Conolly RB, Denslow ND, et al. 2009. Endocrine disrupting chemicals in fish: developing exposure indicators and predictive models of effects based on mechanism of action. Aquat Toxicol 92:168-178; doi:10.1016/j.aquatox.2009.01.013.
4. Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, et al. 2010. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29:730-741; doi:10.1002/etc.34.
5. Ankley GT, Gray LE. 2013. Cross-species conservation of endocrine pathways: a critical analysis of tier 1 fish and rat screening assays with 12 model chemicals. Environ Toxicol Chem 32:1084-1087; doi:10.1002/etc2151.
6. Ankley GT, Jensen KM, Durhan EJ, Makynen EA, Butterworth BC, Kahl MD, et al. 2005. Effects of two fungicides with multiple modes of action on reproductive endocrine function in the fathead minnow (Pimephales promelas). Toxicol Sci 86:300-308; doi:10.1093/toxsci/kfi202.
7. Ankley GT, Jensen KM, Kahl MD, Korte JJ, Makynen EA. 2001. Description and evaluation of a short-term reproduction test with the fathead minnow (Pimephales promelas). Environ Toxicol Chem 20:1276-1290.
8. Ankley GT, Johnson RD. 2004. Small fish models for identifying and assessing the effects of endocrine-disrupting chemicals. ILAR J 45:469-483.
9. Arukwe A, Cangialosi MV, Letcher RJ, Rocha E, Mortensen AS. 2013. Changes in morphometry and association between whole-body fatty acids and steroid hormone profiles in relation to bioaccumulation patterns in salmon larvae exposed to perfluorooctane sulfonic or perfluorooctane carboxylic acids. Aquatic Toxicol 131:219-230; doi:10.1016/j.aquatox.2012.12.026.
10. Austin ME, Kasturi BS, Barber M, Kannan K, MohanKumar PS, MohanKumar SMJ. 2003. Neuroendocrine effects of perfluorooctane sulfonate in rats. Environ Health Perspect 111:1485-1489.
11. Baker ME. 2011. Insights from the structure of estrogen receptor into the evolution of estrogens: Implications for endocrine disruption. Biochemical Pharmacol 82:1-8; doi:10.1016/j.bcp.2011.03.008.
12. Baker ME, Ruggeri B, Sprague LJ, Eckhardt-Ludka C, Lapira J, Wick I, et al. 2008. Analysis of endocrine disruption in southern California coastal fish using an aquatic multispecies microarray. Environ Health Perspect 117:223-230; doi:10.1289/ehp.11627.
13. Bauer-Mehren A, Furlong LI, Sanz F. 2009. Pathway databases and tools for their exploitation: benefits, current limitations and challenges. Mol Syst Biol 5:290; doi:10.1038/msb.2009.47.
14. Bencic DC, Villeneuve DL, Biales AD, Blake L, Durhan EJ, Jensen KM, et al. 2013. Effects of the insecticide fipronil on reproductive endocrinology in the fathead minnow. Environ Toxicol Chem; doi:10.1002/etc.2254 [Online 27 April 2013].
15. Berninger JP, Brooks BW. 2010. Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals. Toxicol Lett 193:69-78; doi:10.1016/j.toxlet.2009.12.006.
16. Bijland S, Rensen PCN, Pieterman EJ, Maas ACE, van der Hoorn JW, van Erk MJ, et al. 2011. Perfluoroalkyl sulfonates cause alkyl chain length-dependent hepatic steatosis and hypolipidemia mainly by impairing lipoprotein production in APOE*3-Leiden CETP mice. Toxicol Sci 123:290-303; doi:10.1093/toxsci/kfr142.
17. Boxall ABA, Rudd MA, Brooks BW, Caldwell DJ, Choi K, Hickmann S, et al. 2012. Pharmaceuticals and personal care products in the environment: What are the big questions? Environ Health Perspect 120:1221-1229; doi:10.1289/ehp.1104477.
18. Bringolf RB, Belden JB, Summerfelt RC. 2004. Effects of atrazine on fathead minnow in a short-term reproduction assay. Environ Toxicol Chem 23:1019-1025.
19. Bulger WH, Muccitelli RM, Kupfer D. 1978. Studies on the in vivo and in vitro estrogenic activities of methoxychlor and its metabolites. Role of hepatic mono-oxygenase in methoxychlor activation. Biochem Pharmacol 27:2417-2423; doi:10.1016/0006-2952(78)90354-4.
20. Burgess-Herbert SL, Euling SY. 2011. Use of comparative genomics approaches to characterize interspecies differences in response to environmental chemicals: challenges, opportunities, and research needs. Toxicol Appl Pharmacol doi:10.1016/j.taap.2011.11.011 [Online 28 November 2011].
21. Burgoon LD, Zacharewski TR. 2008. Automated quantitative dose-response modeling and point of departure determination for large toxicogenomic and high-throughput screening data sets. Toxicol Sci 104:412-418; doi:10.1093/toxsci/kfn083.
22. Capen CC. 1997. Mechanistic data and risk assessment of selected toxic end points of the thyroid gland. Toxicol Pathol 25:39-48; doi:10.1177/019262339702500109.
23. Chen H, Thiagalingam A, Chopra H, Borges MW, Feder JN, Nelkin BD, et al. 1997. Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression. Proc Natl Acad Sci USA 94:5355-5360.
24. Cheng Y, Cui Y, Chen HM, Xie WP. 2011. Thyroid disruption effects of environmental levels perfluorooctane sulfonates (PFOS) in Xenopus laevis. Ecotoxicology 20:2069-2078; doi:10.1007/s10646-011-0749-3.
25. Collins FS, Gray GM, Bucher JR. 2008. Transforming environmental health protection. Science 319:906-907; doi:10.1126/science.1154619.
26. Crofton KM. 2008. Thyroid disrupting chemicals: mechanisms and mixtures. Int J Androl 31:209-23; doi:10.1111/j.1365-2605.2007.00857.x.
27. Crump KS. 1995. Calculation of benchmark doses from continuous data. Risk Anal 15:79-89; doi:10.1111/j.1539-6924.1995.tb00095.x.
28. D'Amato RJ, Loughnan MS, Flynn E, Folkman J. 1994. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91:4082-4085.
29. Degitz SJ, Holcombe GW, Flynn KM, Kosian PA, Korte JJ, Tietge JE. 2005. Progress towards development of an amphibian-based thyroid screening assay using Xenopus laevis. Organismal and thyroidal responses to the model compounds 6-propylthiouracil, methimazole, and thyroxine. Toxicol Sci 87:353-364; doi:10.1093/toxsci/kfi246.
30. Dickhoff WW, Folmar LC, Gorbman A. 1978. Changes in plasma thyroxine during smoltification of coho salmon, Oncorhynchus kisutch. Gen Comp Endocrin 36:229-232; doi:10.1016/0016-6480(78)90027-8.
31. Dodd MHI. 1976. The biology of metamorphosis. I. In Physiology of Amphibia (Lofts B, ed). New York:Academic Press, 467-599.
32. Embry MR, Belanger SE, Braunbeck TA, Galay-Burgos M, Halder M, Hinton DE, et al. 2010. The fish embryo toxicity test as an animal alternative method in hazard and risk assessment and scientific research. Aquatic Toxicol 97(2):79-87; doi:10.1016/j.aquatox.2009.12.008.
33. Eriksen KT, Raaschou-Nielsen O, McLaughlin JK, Lipworth L, Tjønneland A, Overvad K, et al. 2013. Association between plasma PFOA and PFOS levels and total cholesterol in a middle-aged Danish population. PLoS One 8:e56969; doi:10.1371/journal.pone.0056969.t001.
34. European Commission. 2007. Review Report for the Active Substance Flusilazole Finalized in the Standing Committee on Plant Health at its Meeting on 3 March 2006 in View of the Inclusion of Flusilazole in Annex I of Directive 91/414/EEC. Health and Consumer Protection Directorate-General of the European Commission, Brussels, Belgium. Available: http://ec.europa.eu/food/plant/protection/evaluation/existactive/list_flusilazole.pdf [accessed 10 July 2013].
35. Fini JB, Le Mével S, Turque N, Palmier K, Zalko D, Cravedi JP, et al. 2007. An in vivo multiwell-based fluorescent screen for monitoring vertebrate thyroid hormone disruption. Environ Sci Technol 41:5908-5914.
36. Foltenyi K, Greenspan RJ, Newport JW. 2007. Activation of EGFR and ERK by rhomboid signaling regulates the consolidation and maintenance of sleep in Drosophila. Nat Neurosci 10:1160-1167.
37. Food and Agricultural Organization of the United Nations. 2008. FAO Specifications and Evaluations for Agricultural Pesticides: Flusilazole, bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane. New York:United Nations. Available: http://www.fao.org/fileadmin/templates/agphome/documents/Pests_Pesticides/Specs/Flusilazole08.pdf [accessed 10 July 2013].
38. Garcia-Reyero N, Habib T, Pirooznia M, Gust KA, Gong P, Warner C, et al. 2011. Conserved toxic responses across divergent phylogenetic lineages: a meta-analysis of the neurotoxic effects of RDX among multiple species using toxicogenomics. Ecotoxicology 20:580-594; doi:10.1007/s10646-011-0623-3.
39. Gaylor DW, Aylward LL. 2004. An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD). Regul Toxicol Pharmacol 40:9-17; doi:10.1016/j.yrtph.2004.04.002.
40. Goto T, Hiromi J. 2003. Toxicity of 17α-ethynylestradiol and norethindrone, constituents of an oral contraceptive pill to the swimming and reproduction of cladoceran Daphnia magna, with special reference to their synergetic effect. Mar Pollut Bull 47:139-142; doi:10.1016/S0025-326X(03)00052-3.
41. Grim KC, Wolfe M, Braunbeck T, Iguchi T, Ohta Y, Tooi O, et al. 2009. Thyroid histopathology assessments for the amphibian metamorphosis assay to detect thyroid-active substances. Toxicol Pathol 37:415-424; doi:10.1177/0192623309335063.
42. Gunnarsson L, Jauhiainen A, Kristiansson E, Nerman O, Larsson DGJ. 2008. Evolutionary Conservation of Human Drug Targets in Organisms used for Environmental Risk Assessments. Environ Sci Technol 42:5807-5813; doi:10.1021/es8005173.
43. Han X, Nabb DL, Mingoia RT, Yang CH. 2007. Determination of xenobiotic intrinsic clearance in freshly isolated hepatocytes from rainbow trout (Oncorhynchus mykiss) and rat and its application in bioaccumulation assessment. Environ Sci Technol 41:3269-3276; doi:10.1021/es0626279.
44. Hermsen SAB, Pronk TE, van den Brandhof EJ, van der Ven LTM, Piersma AH. 2012. Concentration-response analysis of differential gene expression in the zebrafish embryotoxicity test following flusilazole exposure. Toxicol Sci 127:303-312; doi:10.1093/toxsci/kfs092.
45. Hill AJ. 2005. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 86:6-19; doi:10.1093/toxsci/kfi110.
46. Hill RN, Crisp TM, Hurley PM, Rosenthal SL, Singh DV. 1998. Risk assessment of thyroid follicular cell tumors. Environ Health Perspect 106:447-457.
47. Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M, et al. 2013. The zebrafish reference genome sequence and its relationship to the human genome. Nature 496:498-503; doi:10.1038/nature12111.
48. Huang H, Huang C, Wang L, Ye X, Bai C, Simonich MT, et al. 2010. Toxicity, uptake kinetics and behavior assessment in zebrafish embryos following exposure to perfluorooctanesulphonicacid (PFOS). Aquat Toxicol 98:139-147; doi:10.1016/j.aquatox.2010.02.003.
49. Huang Q, Fang C, Wu X, Fan J, Dong S. 2011. Perfluorooctane sulfonate impairs the cardiac development of a marine medaka (Oryzias melastigma). Aquat Toxicol 105:71-77; doi:10.1016/j.aquatox.2011.05.012.
50. Huggett DB, Cook JC, Ericson JF, Williams RT. 2003. A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish. Hum Ecol Risk Assess Int J 9:1789-1799; doi:10.1080/714044797.
51. Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, et al. 2010. Identification of a primary target of thalidomide teratogenicity. Science 327:1345-1350; doi:10.1126/science.1177319.
52. Judson RS, Kavlock RJ, Setzer RW, Cohen Hubal EA, Martin MT, Knudsen TB, et al. 2011. Estimating toxicity-related biological pathway altering doses for high-throughput chemical risk assessment. Chem Res Toxicol 24:451-462; doi:10.1021/tx100428e.
53. Jukosky JA, Watzin MC, Leiter JC. 2008. Elevated concentrations of ethinylestradiol, 17β-estradiol, and medroxyprogesterone have little effect on reproduction and survival of Ceriodaphnia dubia. Bull Environ Contam Toxicol 81:230-235; doi:10.1007/s00128-008-9462-1.
54. Kavlock R, Chandler K, Houck K, Hunter S, Judson R, Kleinstreuer N, et al. 2012. Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management. Chem Res Toxicol 25:1287-302; doi:10.1021/tx3000939.
55. Kelce WR, Monosson E, Gamcsik MP, Laws SC, Gray LE Jr. 1994. Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol Appl Pharmacol 126:276-285; doi:10.1006/taap.1994.1117.
56. Kleinstreuer NC, Judson RS, Reif DM, Sipes NS, Singh AV, Chandler KJ, et al. 2011. Environmental impact on vascular development predicted by high-throughput screening. Environ Health Perspect 119:1596-1603; doi:10.1289/ehp.1103412.
57. Knöbel M, Busser FJM, Rico Rico A, Kramer NI, Hermens JLM, Hafner C, et al. 2012. Predicting adult fish acute lethality with the zebrafish embryo: relevance of test duration, endpoints, compound properties, and exposure concentration analysis. Environ Sci Technol 46:9690-9700; doi:10.1021/es301729q.
58. Knudsen TB, Houck KA, Sipes NS, Singh AV, Judson RS, Martin MT, et al. 2011. Activity profiles of 309 ToxCast(tm) chemicals evaluated across 292 biochemical targets. J Toxicol 282:1-15; doi:10.1016/j.tox.2010.12.010.
59. Korte JJ, Sternberg RM, Serrano JA, Thoemke KR, Moen SM, Lillegard KE, et al. 2011. Thyroid-stimulating hormone (TSH): measurement of intracellular, secreted, and circulating hormone in Xenopus laevis and Xenopus tropicalis. Gen Comp Endocrinol 171:319-325; doi:10.1016/j.ygcen.2011.02.017.
60. Kostich MS, Lazorchak JM. 2008. Risks to aquatic organisms posed by human pharmaceutical use. Sci Total Environ 389:329-339; doi:10.1016/j.scitotenv.2007.09.008.
61. Laue K, Pogoda HM, Daniel PB, van Haeringen A, Alanay Y, von Ameln S, et al. 2011. Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acid. Am J Hum Genet 89:595-606; doi:10.1016/j.ajhg.2011.09.015.
62. Leloup J, Buscaglia M. 1977. La triiodothyronine, hormone de la métamorphose des amphibiens [in French]. CR Acad Sci Paris 284:2261-2263.
63. Levin ED, Tanguay RL. 2011. Introduction to zebrafish: current discoveries and emerging technologies for neurobehavioral toxicology and teratology. Neurotoxicol Teratol 33:607; doi:10.1016/j.ntt.2011.10.005.
64. MacPhail RC, Brooks J, Hunter DL, Padnos B, Irons TD, Padilla S. 2009. Locomotion in larval zebrafish: influence of time of day, lighting and ethanol. Neurotoxicology 30:52-58; doi:10.1016/j.neuro.2008.09.011.
65. Martindale MQ. 2005. The evolution of metazoan axial properties. Nat Rev Genet 6:917-927; doi:10.1038/nrg1725.
66. Martinović D, Blake LS, Durhan EJ, Greene KJ, Kahl MD, Jensen KM, et al. 2008. Reproductive toxicity of vinclozolin in the fathead minnow: confirming an anti-androgenic mode of action. Environ Toxicol Chem 27:478-488; doi:10.1897/07-206R.1.
67. Marty MS, Carney EW, Rowlands JC. 2011. Endocrine disruption: historical perspectives and its impact on the future of toxicology testing. Toxicol Sci 120:S93-S108; doi:10.1093/toxsci/kfq329.
68. Miller MD, Crofton KM, Rice DC, Zoeller RT. 2009. Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes. Environ Health Perspect 117:1033-1041; doi:10.1289/ehp.0800247.
69. Miyata K, Ose K. 2012. Thyroid hormone-disrupting effects and the amphibian metamorphosis assay. J Toxicol Pathol 25(1):1-9; doi:10.1293/tox.25.1.
70. Nieuwkoop PD, Faber J. 1994. Normal Table of Xenopus laevis (Daudin): A Systematical and Chronological Survey of the Development from the Fertilized Egg Till the End of Metamorphosis (Faber J, ed). 3rd ed. New York:Garland Science.
71. Norris DO. 2007. Vertebrate Endocrinology. Burlington, MA:Elsevier Academic Press.
72. NRC (National Research Council). 2005. Health Implications of Perchlorate Ingestion. Committee to Assess the Health Implications of Perchlorate Ingestion, National Research Council, Washington, DC:National Academies Press. Available: http://www.nap.edu/openbook.php?isbn=0309095689 [accessed 10 July 2013].
73. NRC (National Research Council). 2007. Toxicity Testing in the 21st Century: A Vision and a Strategy. Washington, DC:National Academies Press. Available: http://www.nap.edu/openbook.php?record_id=11970 [accessed 10 July 2013].
74. Olsen RW. 2006. Picrotoxin-like channel blockers of GABAA receptors. Proc Natl Acad Sci USA 103(16):6081-6082; doi:10.1073/pnas.0601121103.
75. Organisation for Economic Co-operation and Development. 2002. Co-Operation on Existing Chemicals. Hazard Assessment of Perfluorooctane Sulfonate (PFOS) and Its Salts. ENV/JM/RD(2002)17/FINAL. Available: http://www.oecd.org/dataoecd/23/18/2382880.pdf [accessed 10 July 2013].
76. Organisation for Economic Co-operation and Development. 2004. Detailed Review Paper on Amphibian Metamorphosis Assay for the Detection of Thyroid Active Substances. ENV/JM/MONO(2004)17. OCED Series on Testing and Assessment, No. 46. Available: http://www.epa.gov/endo/pubs/attachment_e_oecd_amphibian_drp.pdf [accessed 10 July 2013].
77. Pacifici GM, Viani A. 1992. Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences. Clin Pharmacokinet 23:449-468.
78. Paris MM, Laudet VV. 2008. The history of a developmental stage: metamorphosis in chordates. Genesis 46:657-672; doi:10.1002/dvg.20443.
79. Pickford DB. 2010. Screening chemicals for thyroid-disrupting activity: a critical comparison of mammalian and amphibian models. Crit Rev Toxicol 40:845-892. doi:10.3109/10408444.2010.494250.
80. Power DM, Llewellyn L, Faustino M, Nowell MA, Björnsson BT, Einarsdottir IE, et al. 2001. Thyroid hormones in growth and development of fish. Comp Biochem Physiol C Toxicol Pharmacol 130:447-459; doi:10.1016/S1532-0456(01)00271-X.
81. Rovida C, Hartung T. 2009. Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals-a report by the Transatlantic Think Tank for Toxicology (t4). ALTEX 26:187-208.
82. Santos EM, Paull GC, Van Look KJW, Workman VL, Holt WV, van Aerle R, et al. 2007. Gonadal transcriptome responses and physiological consequences of exposure to oestrogen in breeding zebrafish (Danio rerio). Aquat Toxicol 83:134-142; doi:10.1016/j.aquatox.2007.03.019.
83. Schiller V, Wichmann A, Kriehuber R, Muth-Köhne E, Giesy JP, Hecker M, et al. 2013. Studying the effects of genistein on gene expression of fish embryos as an alternative testing approach for endocrine disruption. Comp Biochem Physiol C Toxicol Pharmacol 157:41-53; doi:10.1016/j.cbpc.2012.09.005.
84. Schreiber R, Gündel U, Franz S, Küster A, Rechenberg B, Altenburger R. 2011. Using the fish plasma model for comparative hazard identification for pharmaceuticals in the environment by extrapolation from human therapeutic data. Regulatory Toxicol Pharmacol 61:261-275; doi:10.1016/j.yrtph.2011.08.006.
85. Simmons SO, Fan CY, Ramabhadran R. 2009. Cellular stress response pathway system as a sentinel ensemble in toxicological screening. Toxicol Sci 111:202-225; doi:10.1093/toxsci/kfp140.
86. Sipes NS, Martin MT, Reif DM, Kleinstreuer NC, Judson RS, Singh AV, et al. 2011. Predictive models of prenatal developmental toxicity from toxcast high-throughput screening data. Toxicol Sci 124:109-127; doi:10.1093/toxsci/kfr220.
87. Skolness SY, Blanksma C, Cavallin J, Churchill JJ, Durhan EJ, Jensen KM, et al. 2013. Propiconazole inhibits steroidogenesis and reproduction in the fathead minnow (Pimephales promelas). Toxicol Sci 132:284-297; doi:10.1093/toxsci/kft010.
88. Tarazona JV, Escher B, Giltrow E, Sumpter JP, Knacker T. 2007. Targeting the environmental risk assessment of pharmaceuticals: facts and fantasies. Integr Environ Assess Manag 6(supp):603-613; doi:10.1897/IEAM_2009-052.1.
89. Terrien X, Fini JB, Demeneix BA, Schramm KW, Prunet P. 2011. Generation of fluorescent zebrafish to study endocrine disruption and potential crosstalk between thyroid hormone and corticosteroids. Aquat Toxicol 105:13-20; doi:10.1016/j.aquatox.2011.04.007.
90. Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, et al. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: Maternal and prenatal evaluations. Toxicol Sci 74:369-381; doi:10.1093/toxsci/kfg121.
91. Thienpont B, Tingaud-Sequeira A, Prats E, Barata C, Babin PJ, Raldúa D. 2011. Zebrafish eleutheroembryos provide a suitable vertebrate model for screening chemicals that impair thyroid hormone synthesis. Environ Sci Technol 45:7525-7532; doi:10.1021/es202248h.
92. Thomas RS, Clewell HJ, Allen BC, Wesselkamper SC, Wang NCY, Lambert JC, et al. 2011. Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment. Toxicol Sci 120:194-205; doi:10.1093/toxsci/kfq355.
93. Thomson SA, Baldwin WS, Wang YH, Kwon G, Leblanc GA. 2009. Annotation, phylogenetics, and expression of the nuclear receptors in Daphnia pulex. BMC Genomics 10:500; doi:10.1186/1471-2164-10-500.
94. Tietge JE, Degitz SJ, Haselman JT, Butterworth BC, Korte JJ, Koian PA, et al. 2012. Inhibition of the thyroid hormone pathway in Xenopus laevis by 2-mercaptobenzothiazole. Aquat Toxicol 126C:128-136. doi:10.1016/j.aquatox.2012.10.013.
95. Tillitt DE, Papoulias DM, Whyte JJ, Richter CA. 2010. Atrazine reduces reproduction in fathead minnow (Pimephales promelas). Aquat Toxicol 99:149-159; doi:10.1016/j.aquatox.2010.04.011.
96. U.S. EPA (U.S. Environmental Protection Agency). 2007. Flusilazole: Pesticide Tolerance. Final rule. Fed Reg 72:49654-49660.
97. Vallee M, Aiba K, Piao Y, Palin MF, Ko MSH, Sirard MA. 2008. Comparative analysis of oocyte transcript profiles reveals a high degree of conservation among species. Reproduction 135:439-448; doi:10.1530/REP-07-0342.
98. Villeneuve DL, Ankley GT, Makynen EA, Blake LS, Greene KJ, Higley EB, et al. 2007. Comparison of fathead minnow ovary explant and H295R cell-based steroidogenesis assays for identifying endocrine-active chemicals. Ecotoxicol Environ Saf 68:20-32; doi:10.1016/j.ecoenv.2007.03.001.
99. Villeneuve DL, Garcia-Reyero N. 2010. Vision & strategy: Predictive ecotoxicology in the 21st century. Environ Toxicol Chem 30:1-8; doi:10.1002/etc.396.
100. Villeneuve DL, Garcia-Reyero N, Escalon BL, Jensen KM, Cavallin JE, Makynen EA, et al. 2012. Ecotoxicogenomics to support ecological risk assessment: a case study with bisphenol A in fish. Environ Sci Technol 46:51-59; doi:10.1021/es201150a.
101. Villeneuve DL, Murphy MB, Kahl MD, Jensen KM, Butterworth BC, Makynen EA, et al. 2006. Evaluation of the methoxytriazine herbicide prometon using a short-term fathead minnow reproduction test and a suite of in vitro bioassays. Environ Toxicol Chem 25:2143-2153.
102. Vosges M, Le Page Y, Chung B-C, Combarnous Y, Porcher JM, Kah O, et al. 2010. 17α-ethinylestradiol disrupts the ontogeny of the forebrain GnRH system and the expression of brain aromatase during early development of zebrafish. Aquat Toxicol 99:479-491; doi:10.1016/j.aquatox.2010.06.009.
103. Wetmore BA, Wambaugh JF, Ferguson SS, Sochaski MA, Rotroff DM, Freeman K, et al. 2012. Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment. Toxicol Sci 125:157-174; doi:10.1093/toxsci/kfr254.
104. Williams LR, Aroniadou-Anderjaska V, Qashu F, Finne H, Pidoplichko V, Bannon DI, et al. 2010. RDX binds to the GABAA receptor-convulsant site and blocks GABAa receptor-mediated currents in the amygdala: a mechanism for RDX-induced seizures. Environ Health Perspect 119:357-363; doi:10.1289/ehp.1002588.
105. Woodruff TJ, Zeise L, Axelrad DA, Guyton KZ, Janssen S, Miller M, et al. 2008. Meeting report: moving upstream-evaluating adverse upstream end points for improved risk assessment and decision-making. Environ Health Perspect 116:1568-1575; doi:10.1289/ehp.11516.
106. Yabu T, Tomimoto H, Taguchi Y, Yamaoka S, Igarashi Y, Okazaki T. 2005. Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate. Blood 106:125-134; doi:10.1182/blood-2004-09-3679.
107. Zoeller RT. 2007. Environmental chemicals impacting the thyroid: targets and consequences. Thyroid 17:811-817; doi:10.1089/thy.2007.0107.
108. Zoeller RT, Rovet J. 2004. Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. J Neuroendocrinol 16:809-818; doi:10.1111/j.1365-2826.2004.01243.x.